Contact details

David Dowding

T: +44 20 7809 2162 M: +44 77 1242 9038 Email David | vCard Office: London

Awards

Equity capital markets – Small-mid cap

Equity capital markets – Small-mid cap

ECM-Small mid-cap

ECM-Small mid-cap

David Dowding Partner

Contact details

David Dowding

David Dowding
Partner

T: +44 20 7809 2162 M: +44 77 1242 9038 Email David | vCard Office: London

Specialising in corporate acquisitions and disposals and corporate finance, David has broad experience advising both corporate clients and investment banks on equity capital markets transactions (Official List and AIM). David has particular experience in the healthcare and energy and resources sectors. Clients value his responsiveness and his measured approach to complex issues.
  • Profile
  • Services
  • Sectors

David advises on a broad range of corporate finance and M&A (public and private) matters. As well as regularly advising private companies, he is a trusted adviser to both listed corporates and investment banks. David has a wealth of experience on flotations and secondary offerings, both issuer and bank-side.

David has spent time on secondments in Paris and with the RBS Hoare Govett M&A/Equity Originations teams.

  • Private equity
  • Public and private M&A
  • Equity capital markets
  • Corporate

Advised AIMCo on its £300 million joint venture acquisition and development financing for the BBC Television White City site with Mitsui Fudosan and Stanhope.

Advised Ontex International on its £1 billion acquisition by TPG and Goldman Sachs.

Advised AMP Capital on its successful £200 million consortium bid with JV partner 3i Infrastructure for Danish emergency and rescue services provider Esvagt.

More: Private equity

Advised J.P. Morgan Cazenove as lead financial adviser and sole sponsor on Micro Focus International plc's $8.8 billion merger with the software business segment of Hewlett Packard Enterprises.

Acted for Vectura Group (bidder) on its recommended merger with peer company Skyepharma plc, valuing Skyepharma at £440 million.

Advised Xchanging on takeover offers for it by Capita, Ebix and its eventual £480 million takeover by Computer Sciences Corporation.

Advised Xchanging on its £64.1 million acquisition of the European operations of US-headquartered insurance software company Agencyport Software.

Advised Ontex International on its £1 billion acquisition by TPG and Goldman Sachs.

Advised Babcock International Group on its £350 million acquisition of Devonport Management from Kellogg Brown & Root Holdings, Balfour Beatty and The Weir Group.

Acted for Lloyds Banking Group on the sale to Goldman Sachs of a portfolio of finance assets and equity interests (book value of £1.2 billion).

Tax Systems plc

Advised independent UK private equity firm Bowmark Capital on its £114 million public-to-private takeover of AIM-listed Tax Systems plc.

Acted for life and pensions consolidator Chesnara plc on its £70 million placing and open offer in connection with its €160 million acquisition of L&G Nederland.

Advised Jefferies International as sponsor and joint bookrunner on Oxford Biomedica's £10 million firm placing, placing and open offer.

Advised selling shareholder Elliott Advisers in connection with GAME Digital's £110 million main market IPO and subsequent block trades.

Advised issuer Cambian Healthcare on its £190 million main market IPO.

Advised J.P. Morgan Cazenove, financial adviser to Invensys plc on its £625 million return of cash following the £1.7 billion disposal of its Rail Division to Siemens.

Advised issuer Bayfield Energy Holdings on its £55 million raise and listing on AIM.

Advised Central Asia Metal's £40 million raise and listing on AIM.

Macquarie Capital and Distribution Finance Capital Holdings plc

Advised nominated adviser and broker, Macquarie, on the £96 million AIM IPO of DFC. 

More: Equity capital markets

Acted for Vectura Group on its recommended merger with peer company Skyepharma plc, valuing Skyepharma at £440 million.

Acted for life and pensions consolidator Chesnara plc on its £70 million placing and open offer in connection with its €160 million acquisition of L&G Nederland.

Advised Xchanging on takeover offers for it by Capita, Ebix and its eventual £480 million takeover by Computer Sciences Corporation.

Issuer's counsel to Cambian Healthcare on its £190 million main market IPO.

More: Corporate

  • Technology
  • Mining and minerals
  • Energy and natural resources
  • Healthcare

Advised business processing, procurement and technology services provider Xchanging on its £64.1 million acquisition of Agencyport Software.

Advised Xchanging on its £13 million acquisition of spend analytics company Spikes Cavell.

Counsel to J.P. Morgan Securities and Jefferies International as joint bookrunners on Intel's £51.25 million block trade placing of shares in FTSE 250 Imagination Technologies Group.

Advised selling shareholder Elliott Advisers in connection with GAME Digital's £110 million main market IPO.

More: Technology

Advised AIM-listed Central Asia Metals on its acquisition of the remaining 40 per cent interest in its Kounrad copper project in Kazakhstan.

Acted for Ferrexpo in its acquisition of a further equity stake in Ferrous Resources.

Issuer's counsel on Central Asia Metal's £40 million AIM listing.

More: Mining and minerals

Advised Infinis Energy as purchaser of 18.5 Mega-Watt consented "Maidens Hall/Steadsburn" onshore wind farm project from Peel Group.

Advised AMP Capital on its successful £200 million consortium bid with JV partner 3i Infrastructure for Danish emergency and rescue services provider Esvagt.

Acted for Ferrexpo in its acquisition of a further equity stake in Ferrous Resources.

More: Energy and natural resources

Acted for Vectura Group on its recommended merger with peer company Skyepharma plc, valuing Skyepharma at £440 million.

Acted for Jefferies International as sponsor and joint bookrunner on Oxford Biomedica's £10 million firm placing and placing and open offer.

Advised Cambian Healthcare on its £190 million raising and main market IPO.

More: Healthcare

Awards

Equity capital markets – Small-mid cap

Equity capital markets – Small-mid cap

ECM-Small mid-cap

ECM-Small mid-cap

Latest news & insights

09 Nov 2022

From News

Stephenson Harwood advises WindAcre Partnership on US$16 billion deal

Law firm Stephenson Harwood LLP has advised WindAcre Partnership LLC on its participation in the acquisition of Nielsen Holdings plc.

More

22 Oct 2021

From Insights

LSE publishes new climate reporting guidance

LSE first out of the traps on TCFD-aligned guidance

More

18 Aug 2021

From News

Stephenson Harwood advises on McColl’s £35 million proposed fundraise

Law firm Stephenson Harwood LLP has advised the sponsor and joint brokers, Panmure Gordon and Singer Capital Markets, on McColl's Retail Group plc’s (McColl’s) £35 mil..

More

07 Jun 2021

From News

Stephenson Harwood advises on £70 million takeover of Wey Education by Inspired Education

Law firm Stephenson Harwood LLP has advised Inspired Education, the global education provider, on its £70 million public-to-private takeover of AIM-listed Wey Educatio..

More

27 Apr 2021

From Insights

Facing up to responsibility: Parent liability for overseas subsidiary actions in the English courts

In this article we focus on four key takeaway points from the decision and consider the question – is it now easier to sue a UK parent in the English courts for the ac..

More

23 Feb 2021

From News

Stephenson Harwood advises Acacia Pharma on €27 million fundraise

Law firm Stephenson Harwood LLP has advised Acacia Pharma Group plc on its successful €27 million fundraise, through the placing of 10 million new ordinary shares with..

More

12 Jan 2021

From Insights

A view from the practitioners: AIM at 25 podcast

In this podcast members of the Stephenson Harwood capital markets team talk to some of contributing authors to the Practitioner’s Guide to the AIM Rules

More

02 Nov 2020

From News

Stephenson Harwood partners edit leading AIM guide

Stephenson Harwood partners Tom Nicholls and Tom Page were consultant editors for the eighth edition of ‘A Practitioner's Guide to the AIM Rules’, which was published ..

More

19 Aug 2020

From News

Stephenson Harwood advises Acacia Pharma on €25 million fundraise

Law firm Stephenson Harwood LLP has advised Euronext Brussels-listed Acacia Pharma Group plc on its successful €25 million fundraising through the placing of 12.5 mill..

More

09 Jun 2020

From News

Stephenson Harwood advises Acacia Pharma Group on €10 million deal with Cosmo Pharmaceuticals

Law firm Stephenson Harwood LLP has advised Acacia Pharma Group plc in connection with a debt for equity swap, worth €10 million, with Cosmo Pharmaceuticals NV (Cosmo)..

More

29 Apr 2020

From Insights

Equity fundraising considerations for AIM companies during COVID-19

COVID-19 and related business challenges have forced many companies to review their balance sheets and particularly their cash positions. Many AIM listed companies hav..

More

23 Jul 2019

From Insights

The new Prospectus Regulation

The European Union’s new Prospectus Regulation1 came into force on 20 July 2017, however the bulk of the changes it brings to the existing prospectus regime were imple..

More

09 May 2019

From News

Stephenson Harwood advises Macquarie Capital on £96 million DF Capital IPO

Law firm Stephenson Harwood LLP has advised nominated adviser and broker, Macquarie Capital (Europe) Limited (Macquarie), on the AIM IPO of Distribution Finance Capita..

More

11 Apr 2019

From News

Stephenson Harwood promotes thirteen to partnership

Law firm Stephenson Harwood LLP has promoted thirteen lawyers in its largest round of internal partner promotions. They will take effect on 1 May 2019.

More

28 Mar 2019

From News

Stephenson Harwood advises Bowmark on £114 million takeover of AIM-listed Tax Systems plc

Law firm Stephenson Harwood LLP has advised independent UK private equity firm Bowmark Capital on its public-to-private takeover of AIM-listed Tax Systems plc.

More

print-footer
logo
© Stephenson Harwood LLP 2016. Any reference to Stephenson Harwood in this document means Stephenson Harwood LLP and/or its affiliated undertakings. Any reference to a partner is used to refer to a member of Stephenson Harwood LLP.